In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of the investigational once-weekly […]

NEW ORLEANS — Medications in development would preserve muscle mass and augment fat loss when used in combination with glucagon-like peptide 1 (GLP-1) receptor agonists taken […]

DENVER — Postmenopausal women who receive hormone therapy show significantly greater weight loss when treated with the glucagon-like peptide 1 (GLP-1) receptor agonist drug semaglutide than […]

Cortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules (SPNs) with two distinct layers — one tumorigenic and one tumor suppressive — reported Japanese […]

NEW ORLEANS — Postmenopausal women with osteoporosis may not be receiving all the recommended tests to rule out secondary causes of bone loss prior to treatment […]

VENICE, ITALY — Text messaging with a financial incentive significantly improves weight loss among men with obesity, often from socially deprived groups, lending support to efforts […]

There is an “urgent need” to exploit the potential of social media to educate and positively influence young people with scientific information on obesity, according to […]